Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
First-line pembrolizumab in advanced non–small cell lung cancer patients with poor performance status
PaperCitations, authors & open-access status
First-line pembrolizumab in advanced non–small cell lung cancer patients with poor performance status is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 147 citations, 2020 year and green oa status.
147
Citations
2020
Year
green
OA Status